Private Capital Group’s Jazz Pharmaceuticals JAZZ Stock Holding History

Private Capital Group’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$26K	Hold	166	–	–	0.02%	732
2022 Q1	$26K	Buy	166 +158	+1,975%	+$22.9K	0.01%	917
2021 Q4	$1K	Sell	8 -137	-94%	-$18K	﹤0.01%	1947
2021 Q3	$19K	Sell	145 -37	-20%	-$5.59K	﹤0.01%	1099
2021 Q2	$32K	Buy	182 +32	+21%	+$5.54K	0.01%	852
2021 Q1	$25K	Hold	150	–	–	0.01%	954
2020 Q4	$25K	Hold	150	–	–	﹤0.01%	1087
2020 Q3	$21K	Buy	150 +67	+81%	+$8.31K	﹤0.01%	1074
2020 Q2	$9K	Sell	83 -32	-28%	-$3.54K	﹤0.01%	1371
2020 Q1	$11K	Hold	115	–	–	﹤0.01%	1242
2019 Q4	$17K	Hold	115	–	–	﹤0.01%	1164
2019 Q3	$15K	Buy	+115	New	+$15.4K	﹤0.01%	1308
2019 Q2	–	Sell	-118	Closed	-$17K	–	2318
2019 Q1	$17K	Buy	118 +108	+1,080%	+$14.1K	﹤0.01%	1275
2018 Q4	$1K	Buy	+10	New	+$1.48K	﹤0.01%	2051
2018 Q2	–	Sell	-100	Closed	-$15K	–	2194
2018 Q1	$15K	Hold	100	–	–	﹤0.01%	1194
2017 Q4	$13K	Buy	+100	New	+$13.9K	﹤0.01%	1246

Other funds holding JAZZ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

PCM

Polaris Capital Management Boston, Massachusetts $1.06B AUM 40.82% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Samlyn Capital New York $6.14B AUM 42.05% 1-Year Est. Return

Private Capital Group's JAZZ Position: Q2 2022 in Review

Private Capital Group held its Jazz Pharmaceuticals (JAZZ) position steady in Q2 2022 at 166 shares worth $26K. The position accounts for 0.02% of the portfolio, ranked #732.

Private Capital Group first reported a position in JAZZ in Q4 2017 and has held it in 16 quarters since. The position peaked at $32K in Q2 2021. 468 funds tracked by Wall St. Rank hold JAZZ as of Q2 2022.

Private Capital Group held 166 shares of Jazz Pharmaceuticals worth $26K as of Q2 2022.
Private Capital Group left its Jazz Pharmaceuticals share count unchanged in Q2 2022.
Jazz Pharmaceuticals made up 0.02% of Private Capital Group's portfolio in Q2 2022, its #732 holding.
Private Capital Group first reported a position in Jazz Pharmaceuticals in Q4 2017 and has held it in 16 quarters since.
Private Capital Group's Jazz Pharmaceuticals position peaked at $32K in Q2 2021.
468 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2022.

Based on Private Capital Group's 13F filing for Q2 2022, filed 28 Jul 2022.